Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MYDRIACYL 1 % — DIN 00001007

TROPICAMIDE : 1 % · ALCON CANADA INC · SOLUTION · wholesale supply in Canada

Health Canada status: MARKETED

What is MYDRIACYL?

MYDRIACYL 1 % contains TROPICAMIDE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00001007, held by ALCON CANADA INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 14-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MYDRIACYL used for?

A cycloplegic and mydriatic agent indicated for refraction.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

How much does Tropicamide cost around the world?

Tropicamide is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Belgium publishes a public; Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Saudi Arabiapublic55SAR███.██
United Statesacquisition24USD███.██
Bahrainretail (max)22BHD███.██
Greeceproducer price (ex-factory)22EUR███.██
South Africasingle exit price22ZAR███.██
United Arab Emiratespublic11AED███.██
Belgiumpublic11EUR███.██
MoroccoPPV (public price)11MAD███.██

18 pack listings across 16 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Tropicamide pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Tropicamide in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

7 holders have a Canadian DIN containing Tropicamide, across 10 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
ALCON CANADA INC22MYDRIACYLSourceable in Canada
ODAN LABORATORIES LTD21ODAN-TROPICAMIDESourceable in Canada
BAUSCH & LOMB INC11MINIMS TROPICAMIDESourceable in Canada
PHARMA STULLN INC.20TROPICAMIDENo marketed DIN
PHARMASCIENCE INC10PMS-TROPICAMIDE OPH SLTN 1%No marketed DIN
RICHMOND PHARMACEUTICALS INC.10R.O.-TROPAMIDENo marketed DIN
RIVEX OPHTHALMICS INC.10TROPICAMIDE 1% - LIQ OPH 10MG/MLNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label1 %
Dosage formSOLUTION
RouteOPHTHALMIC
Pack configuration (monograph)15 mL DROP-TAINER dispensers.
StoragePrevent from freezing. Do not refrigerate. Avoid excessive heat. Keep tightly closed.
Shipping classCold chain — validated shipper with temperature monitoring

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.

Substance and classification

Active substanceTropicamide
ATC codeS01FA06
AHFS class52:24.00
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00001007
DIN (unpadded, as printed on some documents)1007
Brand nameMYDRIACYL
Generic / active ingredientTROPICAMIDE : 1 %
Market authorization holderALCON CANADA INC
Health Canada schedulePrescription
ATC codeS01FA06
ATC anatomical main groupS — Sensory organs
ATC therapeutic subgroupS01FA
Current statusMARKETED
Status date14-Mar-2019
Original market date1964-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

How is it administered?

0.5%: 1-2 drops 15-20 mins prior to exam. 1%: 1-2 drops, repeat in 5 mins. Topical ophthalmic use only. Do not inject.

Included because it drives pack selection and wastage. Consult the monograph.

Contraindications

Hypersensitivity to any ingredient; known or suspected narrow angle glaucoma. MYDRIACYL 1% is contraindicated in small infants (< 3 months of age).

Warnings and precautions

May increase IOP; check for glaucoma before use. Contains benzalkonium chloride (remove soft contacts). May cause drowsiness/blurred vision; do not drive until vision is clear. Do not inject.

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

4 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
MINIMS TROPICAMIDE1 %DROPSBAUSCH & LOMB INCMARKETED02148536
MYDRIACYL0.5 %SOLUTIONALCON CANADA INCMARKETED00000981
ODAN-TROPICAMIDE1 %SOLUTIONODAN LABORATORIES LTDMARKETED00622885
ODAN-TROPICAMIDE0.5 %SOLUTIONODAN LABORATORIES LTDDORMANT00627704
PMS-TROPICAMIDE OPH SLTN 1%1 %DROPSPHARMASCIENCE INCCANCELLED POST MARKET00872946
R.O.-TROPAMIDE10 MGLIQUIDRICHMOND PHARMACEUTICALS INC.CANCELLED POST MARKET00896446
TROPICAMIDE1 %SOLUTIONPHARMA STULLN INC.DORMANT02023679
TROPICAMIDE0.5 %SOLUTIONPHARMA STULLN INC.DORMANT02023660
TROPICAMIDE 1% - LIQ OPH 10MG/ML10 MGLIQUIDRIVEX OPHTHALMICS INC.CANCELLED POST MARKET02212919

2 · Same class — other molecules in ATC S01FA

MoleculeCanadian brandsDINsMarketedSourceable
TropicamideMINIMS TROPICAMIDE &middot; MYDRIACYL &middot; ODAN-TROPICAMIDE &middot; PMS-TROPICAMIDE OPH SLTN 1% &middot; +3 more104Yes
AtropineALCON ATROPINE &middot; ATROPINE &middot; ATROPINE 1% &middot; ATROPINE ONT 1% &middot; +6 more103Yes
CyclopentolateCYCLOGYL &middot; CYCLOPENTOLATE &middot; DOM-CYCLOPENTOLATE HCL OPHTHALMIC SOLUTION-1% &middot; MINIMS CYCLOPENTOLATE HYDROCHLORIDE &middot; +2 more93Yes
HomatropineISOPTO HOMATROPINE 2% &middot; ISOPTO HOMATROPINE 5% &middot; MINIMS HOMATROPINE HYDROBROMIDE 2%30Not in Canada
Tropicamide, CombinationsDIOPHENYL-T SOLUTION &middot; PHENYLTROPE OPH SOLN20Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC S01F

ATC subgroupMoleculesDINsMarketed
S01FBPhenylephrine53

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is MYDRIACYL called?

The same molecule, Tropicamide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
MINIMS TROPICAMIDELatinBahrain
MydraneLatinSaudi Arabia
MYDRIATICUMLatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MYDRIACYL

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00001007. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.